SG Americas Securities, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,976
-99.2%
197,884
+197.8%
0.04%
+600.0%
Q3 2022$393,000
+72.4%
66,443
+452.8%
0.01%
+400.0%
Q4 2021$228,000
-68.7%
12,020
-45.1%
0.00%
-66.7%
Q3 2021$729,000
+235.9%
21,896
+291.7%
0.00%
+200.0%
Q2 2021$217,000
-79.2%
5,590
-74.1%
0.00%
-80.0%
Q1 2021$1,042,000
+72.5%
21,612
+86.3%
0.01%
+66.7%
Q4 2020$604,000
-57.0%
11,603
-77.9%
0.00%
-66.7%
Q3 2020$1,405,000
+428.2%
52,511
+284.8%
0.01%
+350.0%
Q2 2020$266,000
+60.2%
13,645
-19.0%
0.00%0.0%
Q1 2020$166,000
+8.5%
16,853
-38.2%
0.00%
+100.0%
Q3 2019$153,000
-42.7%
27,266
-11.6%
0.00%
-50.0%
Q2 2019$267,000
+13.1%
30,858
+5.0%
0.00%0.0%
Q1 2019$236,000
+50.3%
29,377
-23.3%
0.00%
+100.0%
Q4 2018$157,000
+86.9%
38,285
+154.9%
0.00%0.0%
Q3 2018$84,000
-22.9%
15,022
+117.6%
0.00%0.0%
Q4 2014$109,0006,9050.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders